Researchers From Canada, Poland Uncover New Breast Cancer Susceptibility Gene

Apr 27, 2015

|

NEW YORK (GenomeWeb) – A team of researchers from Canada and Poland has uncovered variants in the RECQL gene that are linked to breast cancer susceptibility.

A team led by the University of Toronto's Mohammad Akbari performed whole-exome sequencing on 195 patients with familial breast cancer from Polish and French-Canadian founder populations. From this, the researchers uncovered rare, recurrent RECQL gene mutations in both populations that they then confirmed in some 25,000 additional cases and controls, as they reported in Nature Genetics today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

NIH's Collins on Harassment

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

With Eight Arms and Giant Eyes

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Missing From Trials

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

This Week in Cell

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.

Featured White Papers

Effective Miniaturization of Illumina Nextera XT Library Prep for Multiplexed Whole Genome Sequencing and Microbiome Applications

Miniaturized 16S rRNA Amplicon Sequencing with the Labcyte Echo 525 Liquid Handler for Metagenomic and Microbiome Studies

NGS is Accelerating Therapeutic Antibody Discovery - What Lies Beyond?

Tissue Section Imaging

Sep

20

Featured Webinar

Cloud-based Data and Analysis Tools Yield Novel Insights for Cancer Research

This webinar will provide an overview of how St. Jude Cloud, a public repository of pediatric cancer genomics data and analysis tools, is impacting cancer research.

Oct

02

Featured Webinar

Utilization of Multiple Molecular Testing Methodologies to Aid in Lung Cancer Patient Management

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.

Oct

04

Featured Webinar

Software Tools for NGS-Based Diagnosis of CFTR-Related Diseases in Routine Practice

This webinar will discuss the use of new software tools to support the diagnosis of CTFR-related disorders using next-generation sequencing.

Oct

10

Featured Webinar

Personalization of Oncology Pathways: Clinical Quality Initiatives Amid a Complex Molecular Landscape

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.

Main menu